AM
AMIX.US Autonomix Medical, Inc. Common Stock
- Market cap
- USD 2.80M
- P/E
- -
- P/B
- 0.88x
- ROE
- -168.7%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Sep 2026.
Is AMIX.US undervalued?
Graham numberThe Graham number of Autonomix Medical, Inc. Common Stock cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Autonomix Medical, Inc. Common Stock fundamental analysis
No fundamental analysis for Autonomix Medical, Inc. Common Stock yet.
Autonomix Medical, Inc. Common Stock stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Autonomix Medical, Inc. Common Stock
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders of nervous system. The company's technology platform includes a catheter-based system incorporating microchip-enabled sensing architecture designed to detect low-amplitude neural signals from within the vascular system. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hyperte…
Full company profileAutonomix Medical, Inc. Common Stock financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Autonomix Medical, Inc. Common Stock annual financial statements
| Item | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | - | 0.00 | 0.00 | 0.00 | 0.00 | - |
| Gross Profit | - | - | -81.0K | -183K | -12.0K | - |
| Operating Income | -13.6M | -1.99M | -12.0M | -11.6M | -17.0M | -11.9M |
| EBITDA | -13.6M | -1.99M | -15.3M | -11.1M | -17.0M | -11.7M |
| Net Income | -13.3M | -1.99M | -15.4M | -11.4M | -16.7M | -11.7M |
| EPS | -298 | -44 | -344 | -136 | -49 | -9.39 |
| Balance Sheet | ||||||
| Total Assets | 2.05M | 865K | 9.41M | 9.81M | 7.60M | 8.20M |
| Total Liabilities | 93.2K | 221K | 1.78M | 1.71M | 1.71M | 1.25M |
| Shareholders' Equity | 1.96M | 644K | 7.63M | 8.10M | 5.90M | 6.94M |
| Cash & Short-term Investments | 2.04M | 865K | 8.61M | 9.14M | 7.00M | 7.69M |
| Total Debt | - | - | 1.00M | - | - | - |
| Cash Flow | ||||||
| Operating Cash Flow | -387K | -1.85M | -6.65M | -8.26M | -12.3M | -12.3M |
| Capital Expenditure | 3.00 | 2.00 | 19.0K | 14.0K | 10.0K | 14.0K |
| Free Cash Flow | -387K | -1.85M | -6.67M | -8.27M | -12.3M | -12.3M |
| Ratios | ||||||
| ROE | -680.2% | -309.0% | -202.2% | -140.9% | -283.5% | -168.7% |
| ROA | -649.3% | -230.1% | -164.0% | -116.4% | -219.9% | -142.9% |
| Debt to Equity | - | - | 0.13x | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Debt to Equity
- Total debt divided by shareholders' equity.
Autonomix Medical, Inc. Common Stock dividends
Autonomix Medical, Inc. Common Stock has not paid dividends in the last 5 fiscal years.
Last stock split: 1:21 on Jun 24, 2026.
Who owns Autonomix Medical, Inc. Common Stock
- Insiders 5.49%
- Institutions 7.17%
- Public & others 87.35%
- Shares outstanding 2.05M
- Free float 1.93M
Top funds holding AMIX.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Fidelity Nasdaq Composite Index | 34.9K | 1.78% | 0.00% | Aug 2026 |
| Fidelity Extended Market Index | 13.6K | 0.69% | -0.21% | Sep 2026 |
| Fidelity Total Market Index | 49.00 | 0.00% | 0.00% | Sep 2026 |
Top institutions holding AMIX.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Mariner Wealth Advisors LLC | 50.1K | 2.56% | +1,889.60% | Jun 2026 |
| Allied Private Wealth LLC | 347.00 | 0.02% | 0.00% | Jun 2026 |
| Tower Research Capital LLC | 313.00 | 0.02% | +12.59% | Jun 2026 |
| PNC Financial Services Group Inc | 75.00 | 0.00% | -1.32% | Jun 2026 |
| Investors Research Corporation | 8.00 | 0.00% | -20.00% | Jun 2026 |
| Mercer Global Advisors Inc. | 2.00 | 0.00% | 0.00% | Jun 2026 |
| Networth Advisors, LLC | 1.00 | 0.00% | 0.00% | Jun 2026 |
| HARBOUR INVESTMENTS, INC. | 0.00 | 0.00% | 0.00% | Jun 2026 |
| Key Capital Management Inc | 0.00 | 0.00% | 0.00% | Jun 2026 |
| Ikarian Capital, LLC | 0.00 | 0.00% | -100.00% | Jun 2026 |
| SWAN Capital LLC | 0.00 | 0.00% | 0.00% | Jun 2026 |
| Bank of Montreal | 0.00 | 0.00% | -100.00% | Jun 2026 |
| BMO Capital Markets Corp. | 0.00 | 0.00% | -100.00% | Jun 2026 |
| Global Retirement Partners, LLC. | 0.00 | 0.00% | 0.00% | Jun 2026 |
| UBS Group AG | 0.00 | 0.00% | -100.00% | Jun 2026 |
| NATIONAL BANK OF CANADA /FI/ | 0.00 | 0.00% | 0.00% | Jun 2026 |
| Geode Capital Management, LLC | 0.00 | 0.00% | -100.00% | Jun 2026 |
| LPL Financial Corp | 0.00 | 0.00% | -100.00% | Jun 2026 |
| Virtu Financial LLC | 0.00 | 0.00% | -100.00% | Jun 2026 |
Autonomix Medical, Inc. Common Stock company profile
- Company name
- Autonomix Medical, Inc. Common Stock
- Ticker
- AMIX.US
- Exchange
- USA Stocks
- Listed since
- Jan 29, 2024
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 8
- Fiscal year end
- March
- Address
- 21 Waterway Avenue, The Woodlands, TX, United States, 77380
- Phone
- 713 588 6150
- Website
- autonomix.com
About Autonomix Medical, Inc. Common Stock
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders of nervous system. The company's technology platform includes a catheter-based system incorporating microchip-enabled sensing architecture designed to detect low-amplitude neural signals from within the vascular system. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.
Autonomix Medical, Inc. Common Stock management
8- Mr. Walter V. KlempExecutive Chairman · born 1960
- Mr. Bradley HauserCEO & President · born 1977
- Ms. Lori H. BissonExecutive Vice Chairman · born 1971
- Mr. David A. RobinsCo-Founder & Independent Director · born 1969
- Mr. Trent N. Smith CPAChief Financial Officer · born 1969
- Dr. Robert Schwartz M.D.Co-Founder & Chief Medical Officer · born 1951
- Mr. Landy TothCo-Founder · born 1977
- Ms. Jennifer CookChief Business Officer